Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Held

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Brain Research|July 16, 2013
Repeated blast exposure alters open field behavior recorded under low illuminationEmerald Huang, Mai Ngo, Stuart Yee, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
Journal of Interventional Cardiology|September 8, 2009
Favorable long-term survival in patients undergoing multivessel-PCI compared to predicted prognosis of CABG estimated by EuroSCORE: procedural and clinical determinants of long-term outcomeRalf Lehmann, Stephan Fichtlscherer, Volker Schächinger, et al.
Clinics in Dermatology|June 15, 2010
Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversiesUlrike Leiter, Thomas Kurt Eigentler, Andrea Forschner, et al.
Journal of Cutaneous Pathology|October 11, 2012
Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcomeLaura Held, Gisela Metzler, Thomas K Eigentler, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Journal of Interventional Cardiology|July 20, 2010
Complete revascularization in patients undergoing multivessel PCI is an independent predictor of improved long-term survivalRalf Lehmann, Stephan Fichtlscherer, Volker Schächinger, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
The American Journal of Pathology|December 25, 2012
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanomaLaura Held, Thomas K Eigentler, Gisela Metzler, et al.
Journal of Cutaneous Pathology|October 14, 2020
Metaplastic spiradenocarcinoma: Report of two cases with sarcomatous differentiationLaura Held, Arno Ruetten, Andrea Saggini, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Brain Research|July 16, 2013
Repeated blast exposure alters open field behavior recorded under low illuminationEmerald Huang, Mai Ngo, Stuart Yee, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
Journal of Interventional Cardiology|September 8, 2009
Favorable long-term survival in patients undergoing multivessel-PCI compared to predicted prognosis of CABG estimated by EuroSCORE: procedural and clinical determinants of long-term outcomeRalf Lehmann, Stephan Fichtlscherer, Volker Schächinger, et al.
Clinics in Dermatology|June 15, 2010
Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversiesUlrike Leiter, Thomas Kurt Eigentler, Andrea Forschner, et al.
Journal of Cutaneous Pathology|October 11, 2012
Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcomeLaura Held, Gisela Metzler, Thomas K Eigentler, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Journal of Interventional Cardiology|July 20, 2010
Complete revascularization in patients undergoing multivessel PCI is an independent predictor of improved long-term survivalRalf Lehmann, Stephan Fichtlscherer, Volker Schächinger, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
The American Journal of Pathology|December 25, 2012
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanomaLaura Held, Thomas K Eigentler, Gisela Metzler, et al.
Journal of Cutaneous Pathology|October 14, 2020
Metaplastic spiradenocarcinoma: Report of two cases with sarcomatous differentiationLaura Held, Arno Ruetten, Andrea Saggini, et al.
Pageof 3